Skip to content
10-Q

Quarterly Report

HOOKIPA PHARMA INC.

0001558370-24-011647

← back to feed
Filed
Aug 8, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2024 · Jun 30, 2024 12.54M sh
Shares Diluted Q2 2024 · Jun 30, 2024 12.54M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 8.27M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 7.75M sh
Capex Q2 2024 · Jun 30, 2024 $161K
Capex Q2 2024 · Jun 30, 2023 $719K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$38.53M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$22.18M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $77.15M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $117.1M
Stockholders Equity Q2 2024 · Jun 30, 2024 $86.06M
Stockholders Equity Q2 2024 · Mar 31, 2024 $104.52M
Stockholders Equity Q2 2024 · Dec 31, 2023 $89.86M
Stockholders Equity Q2 2024 · Jun 30, 2023 $112.33M
Stockholders Equity Q2 2024 · Mar 31, 2023 $83.48M
Stockholders Equity Q2 2024 · Dec 31, 2022 $102.52M
Current Liabilities Q2 2024 · Jun 30, 2024 $27.83M
Current Liabilities Q2 2024 · Dec 31, 2023 $41.99M
Total Liabilities Q2 2024 · Jun 30, 2024 $38.98M
Total Liabilities Q2 2024 · Dec 31, 2023 $71.48M
Current Assets Q2 2024 · Jun 30, 2024 $107.35M
Current Assets Q2 2024 · Dec 31, 2023 $147.12M
Total Assets Q2 2024 · Jun 30, 2024 $125.05M
Total Assets Q2 2024 · Dec 31, 2023 $161.34M
Eps Diluted Q2 2024 · Jun 30, 2024 −$1.52
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.38
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$2.18
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$4.86
Eps Basic Q2 2024 · Jun 30, 2024 −$1.52
Eps Basic Q2 2024 · Jun 30, 2024 −$0.38
Eps Basic restated Q2 2024 · Jun 30, 2023 −$2.18
Eps Basic restated Q2 2024 · Jun 30, 2023 −$4.86
Sga Expense Q2 2024 · Jun 30, 2024 $3.95M
Sga Expense Q2 2024 · Jun 30, 2024 $8M
Sga Expense Q2 2024 · Jun 30, 2023 $4.45M
Sga Expense Q2 2024 · Jun 30, 2023 $9.35M
Rd Expense Q2 2024 · Jun 30, 2024 $19.75M
Rd Expense Q2 2024 · Jun 30, 2024 $39.92M
Rd Expense Q2 2024 · Jun 30, 2023 $19.71M
Rd Expense Q2 2024 · Jun 30, 2023 $40.64M
Net Income Q2 2024 · Jun 30, 2024 −$19.1M
Net Income Q2 2024 · Jun 30, 2024 −$4.71M
Net Income Q2 2024 · Mar 31, 2024 $14.38M
Net Income Q2 2024 · Dec 31, 2023 −$81.6M
Net Income Q2 2024 · Jun 30, 2023 −$18.02M
Net Income Q2 2024 · Jun 30, 2023 −$37.7M
Net Income Q2 2024 · Mar 31, 2023 −$19.68M
Operating Income Q2 2024 · Jun 30, 2024 −$22.46M
Operating Income Q2 2024 · Jun 30, 2024 −$11.35M
Operating Income Q2 2024 · Jun 30, 2023 −$21.47M
Operating Income Q2 2024 · Jun 30, 2023 −$44.13M
Revenue Q2 2024 · Jun 30, 2024 $1.29M
Revenue Q2 2024 · Jun 30, 2024 $37.89M
Revenue Q2 2024 · Jun 30, 2023 $2.68M
Revenue Q2 2024 · Jun 30, 2023 $5.86M